CE · Insider Trading
Celanese Corporation Common Stock
Every open-market purchase and sale reported by CE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Chuck Kyrish | SVP & CFO | Buy | +2,300 | +$104.70K |
| 2026-08-13 | Ashley B Duffie | SVP & GC | Buy | +600 | +$27.36K |
| 2026-08-12 | Kim K.W. Rucker | Director | A | +8 deriv. | — |
| 2026-08-12 | Kathryn Hill | Director | A | +0 deriv. | — |
| 2026-08-12 | Deborah J. Kissire | Director | A | +6 deriv. | — |
| 2026-08-12 | Edward G Galante | Director | A | +1,930 | — |
| 2026-08-12 | Mark Christopher Murray | SVP - Acetyls | Buy | +2,153 | +$98.00K |
| 2026-05-13 | Edward G Galante | Director | A | +4,676 | — |
| 2026-05-13 | Christopher J Kuehn | Director | MIXED | −401 | — |
| 2026-05-13 | Kathryn Hill | Director | A | +2,975 | — |
| 2026-05-13 | Kim K.W. Rucker | Director | MIXED | −401 | — |
| 2026-05-13 | Deborah J. Kissire | Director | MIXED | −401 | — |
| 2026-05-13 | Ganesh Moorthy | Director | A | +2,975 | — |
| 2026-05-13 | Michael Koenig | Director | MIXED | +1,962 | −$58.26K |
| 2026-05-13 | Anne P Noonan | Director | A | +2,975 | — |
| 2026-05-13 | Bruce E. Chinn | Director | A | +2,975 | — |
| 2026-03-11 | Edward G Galante | Director | A | +4 deriv. | — |
| 2026-03-11 | Kathryn Hill | Director | A | +0 deriv. | — |
| 2026-03-11 | Jay V Ihlenfeld | Director | A | +6 deriv. | — |
| 2026-03-11 | Deborah J. Kissire | Director | A | +3 deriv. | — |
| 2026-03-11 | Kim K.W. Rucker | Director | A | +5 deriv. | — |
| 2026-03-03 | Ashley B Duffie | SVP & GC | A | +10,431 | — |
| 2026-03-03 | Todd L Elliott | SVP, EM | A | +12,579 | — |
| 2026-03-03 | Chuck Kyrish | SVP & CFO | A | +15,678 | — |
| 2026-03-03 | Aaron M McGilvray | Chief Accounting Officer | A | +1,687 | — |
| 2026-03-03 | Mark Christopher Murray | SVP - Acetyls | A | +10,431 | — |
| 2026-03-03 | Scott A Richardson | CEO & President | A | +50,623 | — |
| 2026-02-18 | Ashley B Duffie | SVP & GC | MIXED | +435 | −$10.82K |
| 2026-02-18 | Chuck Kyrish | SVP & CFO | MIXED | +222 | −$10.58K |
| 2026-02-18 | Aaron M McGilvray | Chief Accounting Officer | MIXED | −15 | −$11.11K |
| 2026-02-18 | Mark Christopher Murray | SVP - Acetyls | MIXED | +848 | −$21.11K |
| 2026-02-18 | Scott A Richardson | CEO & President | MIXED | +2,347 | −$58.47K |
| 2026-01-30 | Kathryn Hill | Director | C | +1,808 | — |
| 2025-12-12 | Scott A Richardson | CEO & President | Buy | +3,800 | +$158.04K |
| 2025-12-11 | Chuck Kyrish | SVP & CFO | Buy | +5,000 | +$205.15K |
| 2025-11-19 | Ashley B Duffie | SVP & GC | A | +6,624 | — |
| 2025-11-19 | Aaron M McGilvray | Chief Accounting Officer | A | +2,980 | — |
| 2025-11-13 | Edward G Galante | Director | A | +5 deriv. | — |
| 2025-11-13 | Timothy Go | Director | A | +0 deriv. | — |
| 2025-11-13 | Kathryn Hill | Director | A | +2 deriv. | — |
| 2025-11-13 | Jay V Ihlenfeld | Director | A | +7 deriv. | — |
| 2025-11-13 | Deborah J. Kissire | Director | A | +4 deriv. | — |
| 2025-11-13 | Kim K.W. Rucker | Director | A | +7 deriv. | — |
| 2025-09-09 | Timothy Go | Director | Buy | +1,039 | +$48.05K |
| 2025-08-18 | Edward G Galante | Director | Buy | +2,400 | +$99.05K |
| 2025-08-18 | Ganesh Moorthy | Director | Buy | +1,000 | +$40.94K |
| 2025-08-18 | Scott McDougald Sutton | Director | Buy | +2,000 | +$81.79K |
| 2025-08-18 | Mark Christopher Murray | SVP - Acetyls | Buy | +2,017 | +$84.37K |
| 2025-08-13 | Edward G Galante | Director | A | +4 deriv. | — |
| 2025-08-13 | Timothy Go | Director | A | +0 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Scott A Richardson | CEO & President | 124,014 | $5.89M |
| David F Hoffmeister | Director | 54,760 | $2.60M |
| Todd L Elliott | SVP, EM | 39,388 | $1.87M |
| Ashley B Duffie | SVP & GC | 32,616 | $1.55M |
| Mark Christopher Murray | SVP - Acetyls | 30,432 | $1.45M |
| Chuck Kyrish | SVP & CFO | 29,114 | $1.38M |
| Edward G Galante | Director | 27,983 | $1.33M |
| Scott McDougald Sutton | COO | 20,381 | $967.92K |
| Kathryn Hill | Director | 19,783 | $939.52K |
| Jay V Ihlenfeld | Director | 15,850 | $752.72K |
| Aaron M McGilvray | Chief Accounting Officer | 12,825 | $609.07K |
| Ganesh Moorthy | Director | 11,990 | $569.41K |
| Bruce E. Chinn | Director | 7,261 | $344.82K |
| Michael Koenig | Director | 5,345 | $253.83K |
| Deborah J. Kissire | Director | 4,075 | $193.52K |
| Timothy Go | Director | 3,876 | $184.07K |
| Christopher J Kuehn | Director | 2,975 | $141.28K |
| Anne P Noonan | Director | 2,975 | $141.28K |
| Kim K.W. Rucker | Director | 56 | $2.66K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.